Michigan House Bill HB5226

Michigan 2025-2026 Regular Session

• Introduced: 11/6/25
• Refer: 11/6/25

Caption

Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.

Impact

If enacted, HB5226 would modify existing health insurance policies, mandating that coverage for the aforementioned pediatric conditions be provided. This change would broaden the scope of coverage for health insurance providers, thereby enhancing access to necessary treatments for affected families. It sets a legal precedent that might influence future health insurance regulations and enhance scrutiny over insurers' obligations toward pediatric care.

Summary

House Bill 5226 proposes an amendment to the Michigan insurance code requiring health insurance policies to include coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, as well as pediatric acute-onset neuropsychiatric syndrome. This would encompass specific treatments, notably intravenous immunoglobulin therapy, among other options. The bill is aimed at ensuring that children suffering from these conditions receive necessary medical care without facing excessive out-of-pocket costs attributable to insurance limitations.

Contention

While the bill aims to address a critical need within pediatric healthcare, potential points of contention include the cost implications for insurance companies and, subsequently, for policyholders. Opponents may argue that adding coverage requirements could lead to increased premiums, impacting the affordability of insurance. Proponents counter that ensuring coverage for necessary medical conditions ultimately benefits public health and reduces long-term healthcare costs by addressing these disorders early.